1Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76:1116-1119.
2R~ubio CA. Antitumoral activity of indomethacin on experimental esophageal tumors. J Natl Cancer Inst 1984; 72:705-707.
3Rubio CA. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer 1986; 58:1029-1031.
4Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res 1998; 58:114-122.
5Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S,Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
6Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C,Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101:635-639.
7Tonelli F, Valanzano R. Sulindac in familial adenomatous polyposis. Lancet 1993; 342:1120.
8Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325:1593-1596.
9Schreinemachers DM, Everson RB. Aspirin use and lung,colon, and breast cancer incidence in a prospective study. Epidemiology 1994, 5:138-146.
10Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R,Imaida K, Hayashi Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1990; 11:393-395.
8Devesa SS,Blot WJ,Fraumeni JF Jr.Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.Cancer,1998,83:2049～2053.
9Schmassmann A,Gebbers JO.Barrett's esophagus:diagnosis and therapy Schweiz Rundsch Med Prax,2005,94:861～868.
10Smith KJ,O'Brien SM,Smithers BM,Gotley DC,Webb PM,Green AC,Whiteman DC.Interactions among smoking,obesity,and symptoms of acid reflux in Barrett's esophagus.Cancer Epidemiol Biomarkers Prev,2005,14:2481～2486.
